Human Genome Epidemiology Literature Finder
Records 1 - 14 (of 14 Records) |
Query Trace: Lung Neoplasms and FOXP3[original query] |
---|
FoxP3 genetic variants and risk of non-small cell lung cancer in the Chinese Han population. Gene 2013 Dec 531 (2): 422-5. He Yan-Qi, Bo Qiao, Yong Wei, Qiu Zhi-Xin, Li Ya-Lun, Li Wei-M |
Association between FOXP3 promoter polymorphisms and cancer risk: A meta-analysis. Oncology letters 2014 Dec 8 (6): 2795-2799. Jiang Ling-Ling, Ruan Li-W |
Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer. Oncology reports 2015 Jan 33 (1): 74-80. Yukawa Takuro, Shimizu Katsuhiko, Maeda Ai, Yasuda Koichiro, Saisho Shinsuke, Okita Riki, Nakata Mas |
Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iranian journal of basic medical sciences 2015 May 18 (5): 465-71. Fazelzadeh Haghighi Maryam, Ali Ghayumi Mohammad, Behzadnia Farzane, Erfani Nasroll |
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 2016 Sep . Kadara H, Choi M, Zhang J, Cuentas E P, Canales J R, Gaffney S G, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons D L, Heymach J, Kaftan E, Townsend J P, Lynch T J, Schlessinger J, Lee J, Lifton R P, Wistuba I I, Herbst R |
Low PD-1 Expression in Cytotoxic CD8 Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Mazzaschi Giulia, Madeddu Denise, Falco Angela, Bocchialini Giovanni, Goldoni Matteo, Sogni Francesco, Armani Giovanna, Lagrasta Costanza Annamaria, Lorusso Bruno, Mangiaracina Chiara, Vilella Rocchina, Frati Caterina, Alfieri Roberta, Ampollini Luca, Veneziani Michele, Silini Enrico Maria, Ardizzoni Andrea, Urbanek Konrad, Aversa Franco, Quaini Federico, Tiseo Marcel |
Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS. Journal of clinical medicine 2019 10 8 (10): . Kalvala Arjun, Wallet Pierre, Yang Lu, Wang Chongkai, Li Haiqing, Nam Arin, Nathan Anusha, Mambetsariev Isa, Poroyko Valeriy, Gao Hanlin, Chu Peiguo, Sattler Martin, Bild Andrea, Manuel Edwin R, Lee Peter P, Jolly Mohit Kumar, Kulkarni Prakash, Salgia Ra |
Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer. Archives of pathology & laboratory medicine 2020 3 144 (10): 1234-1244. Parra Edwin Roger, Jiang Mei, Machado-Rugolo Juliana, Yaegashi Lygia Bertalha, Prieto Tabatha, Farhat Cecília, de Sá Vanessa Karen, Nagai Maria Aparecida, de Lima Vladmir Cláudio Cordeiro, Takagaki Tereza, Terra Ricardo, Fabro Alexandre Todorovic, Capelozzi Vera Lui |
Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2020 1 141 21-31. Yoshimura Katsuhiro, Inoue Yusuke, Tsuchiya Kazuo, Karayama Masato, Yamada Hidetaka, Iwashita Yuji, Kawase Akikazu, Tanahashi Masayuki, Ogawa Hiroshi, Inui Naoki, Funai Kazuhito, Shinmura Kazuya, Niwa Hiroshi, Suda Takafumi, Sugimura Haruhi |
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer. The Journal of pathology 2021 8 255 (3): 243-256. Backman Max, La Fleur Linnéa, Kurppa Pinja, Djureinovic Dijana, Elfving Hedvig, Brunnström Hans, Mattsson Johanna Sofia Margareta, Lindberg Amanda, Pontén Victor, Eltahir Mohamed, Mangsbo Sara, Gulyas Miklos, Isaksson Johan, Jirström Karin, Kärre Klas, Leandersson Karin, Mezheyeuski Artur, Pontén Fredrik, Strell Carina, Lindskog Cecilia, Botling Johan, Micke Patri |
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung. Cancer immunology, immunotherapy : CII 2021 2 70 (9): 2577-2587. Goldmann Torsten, Marwitz Sebastian, Nitschkowski Dörte, Krupar Rosemarie, Backman Max, Elfving Hedvig, Thurfjell Viktoria, Lindberg Amanda, Brunnström Hans, La Fleur Linnea, Mezheyeuski Artur, Mattsson Johanna Sofia Margareta, Botling Johan, Micke Patrick, Strell Cari |
Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients. Frontiers in oncology 2021 11 11 715677. Dezfuli Neda K, Alipoor Shamila D, Dalil Roofchayee Neda, Seyfi Sharareh, Salimi Babak, Adcock Ian M, Mortaz Esmae |
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer. Cancer immunology, immunotherapy : CII 2022 3 71 (10): 2511-2522. Zhang Hongyu, Liu Zilong, Wen Haoyu, Guo Yifan, Xu Fengkai, Zhu Qiaoliang, Yuan Wei, Luo Rongkui, Lu Chunlai, Liu Ronghua, Gu Jie, Ge |
E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis. BMC cancer 2023 6 23 (1): 569. Yu-Ping Chang, Gong-Kai Huang, Yung-Che Chen, Kuo-Tung Huang, Yu-Mu Chen, Chiung-Yu Lin, Chao-Cheng Huang, Meng-Chih Lin, Chin-Chou Wa |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: